NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 17 04:00PM ET
53.79
Dollar change
-0.15
Percentage change
-0.28
%
Index- P/E22.57 EPS (ttm)2.38 Insider Own6.07% Shs Outstand96.90M Perf Week6.92%
Market Cap5.22B Forward P/E4.22 EPS next Y12.75 Insider Trans-0.25% Shs Float91.14M Perf Month-32.74%
Income235.24M PEG0.24 EPS next Q-3.14 Inst Own91.96% Short Float6.69% Perf Quarter-54.05%
Sales1.90B P/S2.74 EPS this Y72.80% Inst Trans3.25% Short Ratio3.30 Perf Half Y-56.53%
Book/sh15.77 P/B3.41 EPS next Y238.29% ROA6.51% Short Interest6.10M Perf Year-54.14%
Cash/sh13.96 P/C3.85 EPS next 5Y92.98% ROE19.71% 52W Range48.01 - 173.25 Perf YTD-55.76%
Dividend Est.- P/FCF- EPS past 5Y- ROI8.23% 52W High-68.95% Beta0.89
Dividend TTM- Quick Ratio3.18 Sales past 5Y38.19% Gross Margin81.24% 52W Low12.04% ATR (14)4.56
Dividend Ex-Date- Current Ratio4.20 EPS Y/Y TTM140.26% Oper. Margin11.47% RSI (14)31.45 Volatility5.01% 6.95%
Employees1372 Debt/Eq0.88 Sales Y/Y TTM52.97% Profit Margin12.37% Recom1.40 Target Price156.87
Option/ShortYes / Yes LT Debt/Eq0.87 EPS Q/Q272.83% Payout0.00% Rel Volume1.03 Prev Close53.94
Sales Surprise4.91% EPS Surprise-20.32% Sales Q/Q65.94% EarningsFeb 26 AMC Avg Volume1.85M Price53.79
SMA20-11.52% SMA50-37.31% SMA200-54.34% Trades Volume1,912,205 Change-0.28%
Date Action Analyst Rating Change Price Target Change
Apr-11-25Initiated Wells Fargo Overweight $115
Apr-02-25Upgrade H.C. Wainwright Sell → Neutral $75
Mar-31-25Downgrade RBC Capital Mkts Outperform → Sector Perform $161 → $87
Feb-11-25Initiated Deutsche Bank Hold $136
Nov-27-24Reiterated Needham Buy $205 → $202
Nov-25-24Initiated H.C. Wainwright Sell $80
Nov-07-24Upgrade Cantor Fitzgerald Neutral → Overweight $152 → $167
Oct-21-24Initiated Jefferies Buy $165
Oct-10-24Resumed Raymond James Outperform $150
Jul-29-24Upgrade RBC Capital Mkts Sector Perform → Outperform $182
Apr-16-25 07:32AM
Apr-15-25 08:30AM
Apr-11-25 02:13PM
Apr-10-25 05:00AM
Apr-09-25 01:45PM
04:50PM Loading…
Apr-08-25 04:50PM
07:30AM
05:14AM
Apr-07-25 08:09AM
07:21AM
Apr-04-25 10:38AM
09:25AM
08:44AM
07:29AM
Apr-03-25 04:27PM
03:37PM Loading…
03:37PM
03:23PM
08:58AM
07:19AM
Apr-01-25 12:40PM
12:16PM
12:15PM
11:50AM
07:23AM
Mar-31-25 05:54PM
04:12PM
01:29PM
11:05AM
09:45AM
09:31AM
04:17PM Loading…
Mar-29-25 04:17PM
Mar-28-25 11:30AM
09:00AM
Mar-26-25 12:31PM
10:17AM
Mar-24-25 08:25AM
Mar-23-25 09:30AM
07:18AM
Mar-21-25 04:46AM
Mar-20-25 01:55PM
12:45PM
09:05AM
01:58AM
Mar-19-25 09:02PM
01:38PM
09:28AM
08:57AM
Mar-18-25 04:01PM
11:55AM
10:42AM
10:29AM
10:21AM
10:21AM
10:17AM
10:08AM
09:29AM
Mar-04-25 04:03AM
Feb-28-25 10:20AM
09:00AM
Feb-27-25 08:50AM
02:19AM
Feb-26-25 11:00PM
05:25PM
04:36PM
04:23PM
04:05PM
09:55AM
Feb-25-25 12:29PM
08:03AM
Feb-20-25 02:12PM
Feb-17-25 09:35AM
Feb-14-25 08:30AM
Feb-12-25 08:30AM
Feb-11-25 10:10AM
Feb-10-25 08:30AM
Feb-09-25 09:10AM
Feb-08-25 09:18AM
Jan-31-25 08:36AM
Jan-30-25 10:35AM
Jan-28-25 05:28AM
Jan-27-25 01:00AM
Jan-20-25 07:52AM
Jan-15-25 09:00PM
Jan-13-25 12:25PM
Jan-07-25 11:19AM
Jan-06-25 08:30AM
Dec-31-24 04:10PM
Dec-29-24 06:45AM
Dec-23-24 10:04AM
Dec-19-24 11:25AM
Dec-18-24 08:30AM
06:45AM
Dec-14-24 09:16PM
Dec-13-24 09:55AM
Dec-06-24 11:31AM
Nov-30-24 06:00AM
Nov-29-24 04:10PM
Nov-28-24 08:15AM
Nov-27-24 09:55AM
07:21AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nicaise ClaudeDirectorMar 12 '25Option Exercise25.189,746245,40430,303Mar 13 08:00 PM
Nicaise ClaudeDirectorMar 12 '25Sale99.642,491248,20327,812Mar 13 08:00 PM
Nicaise ClaudeDirectorMar 12 '25Proposed Sale99.652,491248,226Mar 12 05:33 PM
Estepan Ian MichaelChief Financial OfficerJan 29 '25Option Exercise12.0015,800189,60049,496Jan 31 08:30 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Option Exercise13.7110,500143,95533,340Dec 16 08:00 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Sale124.8410,5001,310,82022,840Dec 16 08:00 PM
Wigzell Hans Lennart RudolfDirectorDec 12 '24Proposed Sale124.8010,5001,310,400Dec 12 05:06 PM
Boor Kathryn JeanDirectorDec 05 '24Sale125.551,636205,4005,880Dec 06 08:00 PM
Boor Kathryn JeanDirectorDec 05 '24Proposed Sale125.551,636205,400Dec 05 04:18 PM
Estepan Ian MichaelChief Financial OfficerAug 30 '24Sale137.365,985822,10033,946Sep 03 08:00 PM
Estepan Ian MichaelOfficerAug 30 '24Proposed Sale137.375,985822,130Aug 30 05:03 PM
Chambers Michael AndrewDirectorAug 16 '24Buy133.8037,0384,955,728284,034Aug 20 08:00 AM
BEHRENS M KATHLEENDirectorJul 03 '24Option Exercise13.9015,000208,500191,839Jul 08 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Option Exercise62.7723,5001,475,09556,086Jun 25 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Sale161.6138,9576,296,02917,129Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 24 '24Sale163.087,8591,281,62121,261Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 25 '24Sale163.233,898636,27117,363Jun 25 08:00 PM
Murray DallanChief Customer OfficerMay 02 '24Sale140.003,635508,90018,125May 06 08:09 PM